XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at the beginning (unaudited) at Dec. 31, 2023 $ 54 $ 306,187 $ 529 $ (283,290) $ 23,480
Balance at the beginning (unaudited) (in shares) at Dec. 31, 2023 54,240,265        
Stock-based compensation   2,840     2,840
Foreign translation adjustment     (686)   (686)
Issuance of restricted stock units   198     198
Issuance of restricted stock units (in shares) 207,058        
Issuance of common stock offerings, net of fees   12     12
Issuance of common stock offerings, net of fees (in shares) 53,290        
Warrants issued in connection with long-term debt   691     691
Net Income (Loss)       (13,152) (13,152)
Balance at the end (unaudited) at Sep. 30, 2024 $ 54 309,928 (157) (296,442) 13,383
Balance at the end (unaudited) (in shares) at Sep. 30, 2024 54,500,613        
Balance at the beginning (unaudited) at Jun. 30, 2024 $ 54 308,874 2,173 (293,674) 17,427
Balance at the beginning (unaudited) (in shares) at Jun. 30, 2024 54,306,415        
Stock-based compensation   891     891
Foreign translation adjustment     (2,330)   (2,330)
ATM activation fees   (41)     (41)
Issuance of restricted stock units   204     204
Issuance of restricted stock units (in shares) 194,198        
Net Income (Loss)       (2,768) (2,768)
Balance at the end (unaudited) at Sep. 30, 2024 $ 54 309,928 (157) (296,442) 13,383
Balance at the end (unaudited) (in shares) at Sep. 30, 2024 54,500,613        
Balance at the beginning (unaudited) at Dec. 31, 2024 $ 55 310,809 4,252 (304,009) 11,107
Balance at the beginning (unaudited) (in shares) at Dec. 31, 2024 54,830,146        
Stock-based compensation $ 1 1,878     1,879
Stock-based compensation (in shares) 297,160        
Issuance of common stock and warrants from rights offerings, net of fees incurred $ 6 5,386     5,392
Issuance of common stock and warrants from rights offerings, net of fees incurred (in shares) 6,249,791        
Issuance of common stock from exercise of warrants $ 1 1,438     1,439
Issuance of common stock from exercise of warrants (in shares) 1,417,208        
Foreign translation adjustment     (8,096)   (8,096)
Net Income (Loss)       (2,701) (2,701)
Balance at the end (unaudited) at Sep. 30, 2025 $ 63 319,511 (3,844) (306,710) 9,020
Balance at the end (unaudited) (in shares) at Sep. 30, 2025 62,794,305        
Balance at the beginning (unaudited) at Jun. 30, 2025 $ 63 319,023 (3,960) (303,540) 11,586
Balance at the beginning (unaudited) (in shares) at Jun. 30, 2025 62,610,376        
Stock-based compensation   488     488
Stock-based compensation (in shares) 183,929        
Foreign translation adjustment     116   116
Net Income (Loss)       (3,170) (3,170)
Balance at the end (unaudited) at Sep. 30, 2025 $ 63 $ 319,511 $ (3,844) $ (306,710) $ 9,020
Balance at the end (unaudited) (in shares) at Sep. 30, 2025 62,794,305